BSE filing, NSE: ENBETRD. Summary written from the filing by ALFA Finder's alert engine.
Enbee Trade & Finance Ltd: key numbers
- Share price
- ₹0.24
- Market cap
- ₹16.73 Cr
- Revenue (annual)
- ₹30.62 Cr
- Net profit (annual)
- ₹12.52 Cr
- P/E (TTM)
- 1.2×Sector 19.7×
- Promoter holding
- 2.18%-9.47% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Enbee Trade & Finance Ltd
All →Enbee Trade & Finance Other Announcement
Enbee Trade & Finance Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI Listing Regulations for the quarter ended September 30, 2026.
Enbee Trade & Finance Promoter Selling: ₹0.22 Cr
Promoter group members sold shares of Enbee Trade & Finance Ltd via open market transactions worth a total of Rs.0.22 Crore.
- Value
- ₹0.22 Cr
Enbee Trade & Finance Promoter Selling: ₹0.16 Cr
Promoter Amarr Narendra Galla sold 64.50 lakh shares of Enbee Trade and Finance Ltd via the open market. The transaction is valued at ₹0.16 Crore.
- Value
- ₹0.16 Cr
- Promoter stake change
- -0.92%
Enbee Trade & Finance Promoter Selling: ₹0.06 Cr
Promoter Ssamta Amar Gaala sold 24,90,708 shares of Enbee Trade and Finance Limited via the open market. The transaction is valued at ₹0.06 Crore.
- Value
- ₹0.06 Cr
Enbee Trade & Finance Promoter Selling
Promoter Ssamta Amar Gaala sold 24,90,708 shares (0.36% stake) of Enbee Trade & Finance Ltd via open market on September 29, 2026.
- Promoter stake change
- -0.36%
Enbee Trade & Finance Annual General Meeting
Enbee Trade & Finance Ltd held its 41st Annual General Meeting on September 30, 2026. The company adopted financial statements and re-appointed a Whole-time director.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.